GLOBAL WELLNESS STRATEGIES
Global Wellness Strategies is helping companies create sustainable products that elevate our health, wellness and consciousness.  The present focus is on hemp-infused functional mushrooms and psychedelics.
Previous slide
Next slide

WHO WE ARE

Global wellness strategies invests in cutting edge biotechnology research. Our strategy allows us to place investments into companies from start up to commercialization. We focus on scalability and differentiation which can potentially bring radical benefits to patients and life changing treatments.

WHAT WE DO

Our investment strategy is focused on the specific areas of pain, depression and mental illness. By investing in pioneering techniques such as micro-dosing using organic compounds and synthetic molecules, we are focussing on ground breaking research with the aim of providing superior wellness benefits with less side effects, better for people and the planet.
We understand that addressing perceptions and being part of the education process into these new substances and their application is essential in bringing the products from idea to development to market. The requirement for credible research, peer reviewed studies, trials and patenting running along with legislative and government approval is an area we specialize in.

WHAT IS BIOTECHNOLOGY

Biotechnology is often described as the use of living organisms and molecular biology to produce products, often in the health and medicine sectors. Often sitting at the cutting edge of the next medical breakthrough.

Wellness for All

Wellness is a choice of a lifestyle and we hope to help balance your mind, body and spirit.
Experienced team

Over 100 years of experience in business, consulting, capital markets, corporate finance, and healthcare services.

Advisory Services

We help accelerate business plans and achieve revenues; driving significant growth to investors as well as our shareholders.

Relationship Building

We partner with first mover, high growth companies, and provide them with access to capital, resources, and infrastructure.

brand development

We take an active role in building brand recognition from inception through to execution.

OUR LATEST NEWS

XTACY Therapeutics Provides Bi-Weekly MCTO Status Update

XTACY Therapeutics Provides Bi-Weekly MCTO Status Update

Vancouver, February, 13, 2024  – XTACY THERAPEUTICS CORP. (CSE: XTCY) (Frankfurt: O3X4) (OTCQB: XTCYF) (the…

XTCY Announces LOI with AVM Biotechnology

XTCY Announces LOI with AVM Biotechnology

Vancouver, February 7th 2024 – XTACY THERAPEUTICS CORP. (CSE: XTCY) (Frankfurt: O3X4) (OTCQB: XTCYF) (“Xtacy”…

XTCY Announces A Management Cease Trade Order

XTCY Announces A Management Cease Trade Order

Vancouver   January 30, 2024  – XTACY THERAPEUTICS CORP. (CSE: XTCY) (Frankfurt: O3X4) (OTCQB: XTCYF)…